• Acid-Responsive Polymers Improve RNA Transfection

  2026-10-01

  Cheung, Fuchs, and Shoichet developed acid-responsive polymer additives that improve RNA dissociation from lipid nanoparticles after endosomal disruption, rather than primarily increasing uptake or endosomal escape. Hybrid polymer–lipid nanoparticles enhanced siRNA potency and mRNA transfection across cell-based models, providing a practical strategy for improving payload utilization while avoiding more aggressive membrane-disruptive designs.

• Irinotecan: From DNA Damage to Translation

  2026-09-30

  A mechanism-led guide to using Irinotecan and CPT-11 in colorectal cancer research, connecting prodrug activation, assay design, xenograft validation, and the translational implications of chemotherapy-induced nausea and vomiting.

• Rucaparib and the Next Frontier of DDR Signaling

  2026-09-30

  Rucaparib (AG-014699, PF-01367338) offers a mechanistically rich platform for studying PARP1 inhibition, persistent DNA damage, radiosensitization, and context-dependent apoptosis. This thought-leadership perspective connects established DNA repair biology with emerging evidence that RNA Pol II loss can actively signal cell death, while distinguishing validated mechanisms from testable translational hypotheses.

• RSL3–PARP1 Crosstalk in Ferroptosis and Apoptosis

  2026-09-29

  The 2025 study identifies PARP1 as a mechanistic bridge between RSL3-induced ferroptosis and apoptosis, revealing both caspase-dependent PARP1 cleavage and depletion of full-length PARP1 through altered m6A-mediated translation. Its findings connect redox stress, epigenetic RNA regulation, and PARPi-resistant tumor growth, while suggesting that ferroptosis studies benefit from orthogonal measurements of caspase signaling and PARP1 status.

• Dual-Network Microspheres for IVDD Inflammation

  2026-09-29

  The reference study develops PMCCP, an elastic dual-network hydrogel microsphere that combines stimulus-responsive miR-155 delivery with metal-phenolic-network-mediated microenvironment regulation. In vitro and in vivo findings indicate that the platform can reduce inflammatory stress, inhibit nucleus pulposus cell apoptosis, and help restore disc-cell function under degenerative conditions.

• MG-132 Workflows for Proteasome and Apoptosis

  2026-09-28

  MG-132, also known as Z-LLL-al, provides a rapid pharmacologic route for testing how proteasome activity shapes apoptosis, cell-cycle behavior, ROS, and protein stability. This article translates cardiomyocyte findings involving Septin4, VHL, and HIF-1α into practical workflows while emphasizing dose control, pathway-specific controls, and troubleshooting.

• Imatinib (STI571) Workflows for Kinase Research

  2026-09-28

  Build reproducible kinase-inhibition experiments with Imatinib (STI571), from acute phosphorylation readouts to longer cell-proliferation studies. A recent erythroleukemia study also offers a focused way to test imatinib in combination experiments without confusing kinase inhibition with erythroid differentiation.

• Puromycin dihydrochloride: Selection and Translation Guide

  2026-09-27

  Puromycin dihydrochloride provides a way to select pac-expressing cell populations and to perturb protein synthesis in translation-focused experiments. It is not a universal selection dose: establish sensitivity in the target cells, and avoid using it where untreated viability or translation must be preserved.

• DRB and RNA Fate: Separating Transcription from Translation

  2026-09-26

  Learn how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) can help distinguish transcriptional effects from downstream changes in RNA stability and translation. A recent female germline stem cell study provides a practical framework for interpreting these layers without conflating them.

• Prednisone: Interpreting Immune Assay Evidence

  2026-09-25

  Prednisone is a synthetic corticosteroid used to study lymphocyte cell-cycle arrest, cytokine suppression, and apoptosis. This article connects those defined cellular effects to a broader lesson from botanical metabolomics: interpret biological responses in light of exposure identity, assay context, and evidence limits.

• Latrunculin A and the Mechanics of Axon Regrowth

  2026-09-25

  Latrunculin A is a reversible inhibitor of actin assembly that can help researchers test how cytoskeletal remodeling relates to mechanically guided cell behavior. This article connects actin perturbation to a recent DRG axon-regeneration study while clarifying what the evidence does—and does not—show.

• Patient-Derived Gastric Cancer Assembloids: Key Findings

  2026-09-24

  This study builds patient-derived gastric cancer assembloids by combining tumor organoids with stromal cell populations isolated from the same tumor, then shows that stromal inclusion can change gene-expression profiles and drug responses. The model offers a more complete setting for studying tumor–stroma interactions and resistance, while its patient-specific results and methodological limits matter when interpreting drug-screening data.

• Caspase-3 Fluorometric Assay Kit in RCC Research

  2026-09-24

  Pair resveratrol treatment with DEVD-dependent activity measurement to test how apoptosis changes when autophagy is altered in renal cancer cells. This practical guide covers controls, workflow choices, data interpretation, and troubleshooting with the Caspase-3 Fluorometric Assay Kit.

• Q-VD(OMe)-OPh in Apoptosis Workflow Design

  2026-09-23

  Use Q-VD(OMe)-OPh to test whether caspase-dependent apoptosis contributes to a treatment response—without mistaking reduced apoptosis for proof that every form of cell death has been blocked. This workflow connects the inhibitor to a colorectal cancer resistance study and offers practical controls, dose-finding guidance, and interpretation limits for apoptosis assays.

• OTUD7B, p62, and IRF3 in Antiviral Immunity

  2026-09-23

  The reference study identifies OTUD7B as a negative regulator of antiviral immunity that activates SQSTM1/p62 through deubiquitination and promotes selective autophagic degradation of IRF3. Its findings connect ubiquitin-chain editing, cargo-receptor oligomerization, and type I interferon control, providing a mechanistic framework for studying how antiviral signaling is terminated.

8829 records 1/589 page Next 12345 下5页 Last page